Coriolin C displays activity against Gram-positive bacteria, weakly against Gram-negative bacteria, as well as yeast and Trichomonas vaginalis. At a concentration of 5 μg/mL, Coriolin C can inhibit 61.6% of the growth of Yoshida sarcoma, though it does not affect Ehrlich ascites carcinoma in animals.